Search research articles
Contact Us
Filters
Showing results (381-390 of 634) with videos related to
Page
of 64
Sort By:
Journal of Clinical Pharmacology
|
October 3, 2009
A systematic review and empirical analysis of the relation between dose and duration of drug action
Dyfrig A Hughes, Jeffrey K Aronson
The Quarterly Journal of Medicine
|
February 1, 1990
HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias
J K Aronson, L L Ng
BMJ Evidence-Based Medicine
|
August 21, 2020
Analysis of reports of unintended pregnancies associated with the combined use of non-enzyme-inducing antibiotics and hormonal contraceptives
Jeffrey K Aronson, Robin E Ferner
Anaesthesia
|
January 1, 1986
Transdermal hyoscine (scopolamine) and postoperative vomiting
J K Aronson, J W Sear
BMJ (Clinical Research Ed.)
|
April 24, 2020
Remdesivir in covid-19
Robin E Ferner, Jeffrey K Aronson
The Quarterly Journal of Medicine
|
January 1, 1980
The use of colour vision measurement in the diagnosis of digoxin toxicity
J K Aronson, A R Ford
Dermatology Online Journal
|
March 13, 2024
Recurrence of non-sexually acquired acute genital ulceration following COVID-19 vaccination
Christy L Waterman, Iris K Aronson
The British Journal of Venereal Diseases
|
August 1, 1981
Jarisch-Herxheimer reaction in complement-depleted rabbits. Histological and immunofluorescence studies of early cutaneous lesions
I K Aronson, K Soltani, F Brickman
British Journal of Clinical Pharmacology
|
April 1, 1977
Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution
J K Aronson, D G Grahame-Smith
Journal of the Royal Society of Medicine
|
May 7, 2009
The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?
Jeremy Howick, Paul Glasziou, Jeffrey K Aronson
Page
of 64
Search research articles
Search
Showing results (381-390 of 634) with videos related to
Sort By:
Page
of 64
Journal of Clinical Pharmacology
|
October 3, 2009
A systematic review and empirical analysis of the relation between dose and duration of drug action
Dyfrig A Hughes, Jeffrey K Aronson
The Quarterly Journal of Medicine
|
February 1, 1990
HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias
J K Aronson, L L Ng
BMJ Evidence-Based Medicine
|
August 21, 2020
Analysis of reports of unintended pregnancies associated with the combined use of non-enzyme-inducing antibiotics and hormonal contraceptives
Jeffrey K Aronson, Robin E Ferner
Anaesthesia
|
January 1, 1986
Transdermal hyoscine (scopolamine) and postoperative vomiting
J K Aronson, J W Sear
BMJ (Clinical Research Ed.)
|
April 24, 2020
Remdesivir in covid-19
Robin E Ferner, Jeffrey K Aronson
The Quarterly Journal of Medicine
|
January 1, 1980
The use of colour vision measurement in the diagnosis of digoxin toxicity
J K Aronson, A R Ford
Dermatology Online Journal
|
March 13, 2024
Recurrence of non-sexually acquired acute genital ulceration following COVID-19 vaccination
Christy L Waterman, Iris K Aronson
The British Journal of Venereal Diseases
|
August 1, 1981
Jarisch-Herxheimer reaction in complement-depleted rabbits. Histological and immunofluorescence studies of early cutaneous lesions
I K Aronson, K Soltani, F Brickman
British Journal of Clinical Pharmacology
|
April 1, 1977
Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution
J K Aronson, D G Grahame-Smith
Journal of the Royal Society of Medicine
|
May 7, 2009
The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?
Jeremy Howick, Paul Glasziou, Jeffrey K Aronson
Page
of 64